and the Mangham protocol (91.58%). Eleven of 15 protocols for Specificity-A and 12 of 15 protocols for Specificity-B achieved ≥ 50%. Clinical risks were 6.84% to 18.95% while financial wastes were 33.56% to 68.37% for Specificity-A and 31.76% to 66.86% for Specificity-B. Interaural difference parameters indicating highest mean sensitivity rates in the order of ≥ 10dB, ≥ 15dB, and ≥ 20dB, while frequencycomparison parameters were in the order of "two adjacent frequency," "single frequency," and "averaged multifrequency" comparison. Mean specificity patterns were the exact opposite.
Objective: 1) Understand the audiologic and vestibular toxicity associated with Adoptive Cell Therapy (ACT) for melanoma, which utilizes T-cells engineered with receptors to target the tumor-associated antigens MART-1 and gp100. 2) Investigate the use of intratympanic steroid injections in the treatment of audiovestibular dysfunction associated with ACT for melanoma.
Method: Retrospective review of 33 patients with metastatic melanoma nonresponsive to conventional therapy who underwent ACT with modified T-cells targeting or gp100 (n = 14) from 2007 to 2008. All patients received serial audiometric testing. Vestibular testing was performed on patients with vestibular complaints. Patients with significant hearing loss received intratympanic steroid injections.
Results: Out of 33 patients, 16 had no hearing loss, 9 had mild hearing loss, and 8 had moderate hearing loss posttreatment. Ten patients received intratympanic steroid injections for mild (n = 3) or moderate (n = 7) hearing loss. Of those with mild hearing loss all but one recovered fully. Five of 8 patients with moderate hearing loss recovered to baseline hearing levels and 3 had partial recovery. There was vestibular dysfunction in 7 patients who underwent vestibular testing, one recovered fully, and the others showed partial recovery or no recovery. The number of modified T-cells infused for therapy correlated with the degree of audiovestibular deficit.
Conclusion: ACT targeting pigmented cell antigens is a novel therapy for melanoma that is associated with hearing loss and vestibular dysfunction. The presumed mechanism of autoimmune attack on normal melanocytes in the stria vascularis of the cochlea and vestibular organs demonstrates the importance of melanocytes in normal inner ear function. Method: Twenty-two TB from 12 patients with otogenic meningitis and 27 TB from 17 patients with otitis media without meningitis were histopathologically examined. The presence, the amount, and localization of biofilm, fluid, and pathologic diagnosis have been noted. Data were compared between the groups with and without otogenic meningitis.
Otology/Neurotology

Biofilm in Human Temporal Bones with Otogenic Meningitis
Results: Biofilm formation has been observed in 19 of 22 TB with otogenic meningitis group and 7 of 27 TB with otitis media/without otogenic meningitis group (P .05). The most common localization of biofilm was in the round window, and it was least common in the Eustachian tube. Biofilm was also present in other areas, including the oval window, facial recess, sinus tympani, mastoid, and inner ear.
Conclusion: Biofilm is a very frequent finding in patients with otogenic meningitis. It seems that the eradication of the biofilm from the hidden areas of the middle ear cleft could be important to prevent any complications such as meningitis. 
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Biofilm in Human Temporal Bones with Pneumococcal Otitis Media
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Method: Thirty-seven TB from 20 cases with COM were selected based on positive blood cultures for Streptococcus pneumonia. The presence, amount, and localization of biofilm, and fluid, type of inflammatory cells, labyrinthitis, use of antibiotics, and coinfection of H influenza were noted. Data were compared between the groups with/without biofilm.
Results: Biofilms were observed in 22 (59%) of the 37 TB with COM. The most common anatomic localization of biofilm was facial recess, the least common was the Eustachian tube. When comparing biofilm positive and negative groups there was statistical significance in the correlation regarding type of inflammatory cells (P .05).
Conclusion:
There is higher incidence of biofilm in chronic otitis media with pneumococcal infection. Because biofilms can be found more commonly in obscure areas such as facial recess and sinus tympany and less localized in well aerated areas such as the Eustachian tube, radical cleaning of those areas and optimum aeration seem essential to avoid recurrence of infection.
Otology/Neurotology
Biofilm Potential of Common Otopathogens Carolyn P. Ojano-Dirain (presenter); Patrick J. Antonelli, MD Objective: Posttympanostomy tube (TT) otorrhea has been linked to microbial biofilms. TTs may be exposed to a wide range of microbes. The purpose of this study was to compare the TT-biofilm forming propensity of common otopathogens, Pseudomonas aeruginosa (PA), Staphylococcus aureus (SA), Haemophilus influenzae (HI), and Streptococcus pneumoniae (SP).
Method: Fluoroplastic coupons were exposed to plasma and cultured with 3 strains of PA, SA, HI, or SP for 2, 4, or 7 days. Half of the coupons were treated with antibiotics to kill planktonic bacteria. Total and biofilm colony counts and electron microscopy were performed.
Results: SA formed mature biofilm after 2 days, not different from 4-or 7-day biofilms (P > .05), and was most tolerant to antibiotic treatment. PA also formed biofilms at 2 days, reached a plateau at 4 days (P > .05), and decreased at 7 days (P < .01). HI formed biofilm only after 4 days (P ≤ .04). SP did not form biofilm without catalase supplementation. With catalase, one SP strain showed a delay in biofilm formation similar to HI (P < .0001) while the other 2 strains formed biofilms after 2 days.
Conclusion: TT biofilm formation occurs with common middle ear pathogens, but most readily with SA and PA. Further investigation is needed to determine if these findings may in part explain the occasionally refractory nature of post-TT otorrhea associated with SA and PA.
Body Stabilization in Benign Paroxysmal Positional Vertigo
Cristiane A. Kasse, PhD (presenter); Fatima Branco Barreiro; Graziela Santana; Juliana Gazzola; Flavia Dona, PhD; Renata Coelho Scharlach, PhD
Objective: Evaluate the influence of Benign Paroxysmal Positional Vertigo (BPPV) in the balance control of the elderly after Epley's maneuver and understand whether a reposition maneuver is enough to recover balance control.
Method: Prospective study of 33 elderly patients with vertical canal BPPV seen in a tertiary center. Dizziness Handicap Inventory (DHI) and static posturography were determined before and after Epley's maneuver. The parameters of the Balance Rehabilitation Unit (BRU) static posturography analyzed were: the limit of stability (LOS) and body sway velocity (VOS).
Results:
The DHI total and the subscale scores improved (P = .001) after the treatment in all aspects. There was statistically significant improvement of the LOS pre-and posttreatment (P = .001). Eight of 10 visual-vestibular stimuli had statistically significant improvement after treatment: with eyes closed (P = .001); over foam and eyes closed (P = .002); saccadic stimulation (P = . 043); horizontal optokinetic stimulation (P = .015); 2 different verticaloptokinetic stimulations (P = . 003, P = . 009); two different visual-vestibular stimulations (P = .003, P = .047). The VOS showed statistical significance after treatment for eyes closed (P = .001); on foam and eyes closed (P = .005); horizontal optokinetic stimulus (P = .042); vertical optokinetic stimulus (P = .027); horizontal visual vestibular stimulus (P = .002); vertical visual vestibular stimulus (P = .018).
Conclusion:
Elderly patients with BPPV present impairment of static postural control in vestibular conflicts. The maneuver promotes remission of symptoms, increases the limit of stability, and improves the control of postural balance in the conditions of somatosensory, visual, and visual-vestibular conflicts.
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Cadaveric Percutaneous Ci with AB, Cochlear, and Medel Electrodes Theodore R. McRackan, MD (presenter); Benoit Dawant; Grégoire S. Blachon; Robert F. Labadie, MD, PhD; Jack Noble, MS; Ramya Balachandran, PhD Objective: 1) Describe advances made in percutaneous cochlear implantation (PCI) that involves a minimally invasive approach to the cochlea via a single, image-guided drill pass from the lateral cranium through the facial recess. 2)
